Loading...
Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...
Saved in:
| Published in: | J Neurogastroenterol Motil |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Korean Society of Neurogastroenterology and Motility
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/ https://ncbi.nlm.nih.gov/pubmed/29605979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|